• Organogenesis entered an at-the-market equity distribution agreement to sell up to USD 75 million of Class A common stock.
• BTIG, LLC and Citizens JMP Securities will act as sales agents for the offering.
• Shares may be sold from time to time on Nasdaq or other trading markets, subject to company instructions.
• Agents will receive commissions of up to 3% of gross sales proceeds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organogenesis Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-338321), on August 06, 2026, and is solely responsible for the information contained therein.